Recombinant Human MIA-2 - 20 μg
MIA2 functions as a tumor suppressor in hepatocellular carcinoma. It is a novel acute phase protein predominantly expressed in hepatocytes of the liver. MIA2 expression increases in response to liver damage associated with chronic liver diseases and is significantly elevated in patients with severe fibrosis. The protein is induced by key mediators such as IL-6, TGF-β, and factors present in conditioned medium from activated hepatic stellate cells, highlighting its role in liver pathology and fibrotic responses. This makes MIA2 a critical marker and functional player in liver health and disease.
Product Specifications
Target
MIA-2
Shipping Conditions
Next Day Ambient
Storage Conditions
The lyophilized protein should be stored desiccated at -20°C. The reconstituted protein can be stored for at least one week at 4°C. For long-term storage of the reconstituted protein, aliquot into working volumes and store at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Formulation
Before freeze-drying (lyophilization), the MIA2 protein was at a concentration of 1mg/mL in an aqueous solution containing 20 mM Phosphate buffer pH 7.2 - 7.4, 150 mM NaCl.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP40468_P050-FITC 100 µL
TAF15 Antibody - N-terminal region : FITC (ARP40468_P050-FITC)
Sign In for Pricing
View Details 479516 100 µL
DNAJB8 (DnaJ Homolog Subfamily B Member 8, DnaJ Heat Shock Protein Family (Hsp40) Member B8)
Sign In for Pricing
View Details 
